STAB
$0.03
Statera Biopharma
$.00
5.16%
STAB
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Jun 12
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when STAB reports earnings?
Beat
Meet
Miss

Where is STAB's stock price going from here?
Up
Flat
Down
Stock chart of STAB
Analysts
Summary of analysts' recommendations for STAB
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Statera BioPharma is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Statera BioPharma, formerly known as Cytocom Inc., is based in FORT COLLINS, Colo.